SpectraScience, Inc. (SCIE)

Market Cap	n/a
Revenue (ttm)	n/a
Net Income (ttm)	-5.35M
Shares Out	n/a
EPS (ttm)	-0.00
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,000,000
Average Volume	347,012
Open	0.0000
Previous Close	0.0000
Day's Range	0.0000 - 0.0000
52-Week Range	0.0000 - 0.0001
Beta	35.33
RSI	46.30
Earnings Date	n/a

About SpectraScience

SpectraScience, Inc. develops and markets a technology platform to instantly determine whether a tissue is normal, pre-cancerous, or cancerous without the need for a physical biopsy in the United States, Europe, and internationally. It offers WavSTAT3 optical biopsy system to determine whether a colon tissue is normal, pre-cancerous, or cancerous without physically removing tissue from the body; and WavSTAT4 optical biopsy system, a colon diagnostic product that operates by using UV laser light to optically illuminate and analyze tissue, enabli...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1983
• Employees: 7
• Stock Exchange: OTCMKTS
• Ticker Symbol: SCIE

Financial Performance

In 2016, SpectraScience's revenue was $5,150, a decrease of -21.97% compared to the previous year's $6,600. Losses were -$4.47 million, 22.9% more than in 2015.